International Journal of Hospital Pharmacy


Summary of the Clinical Pharmacist’s Role in the Management of Acute Pancreatitis: A Clinical Review

Review Article of International Journal of Hospital Pharmacy Summary of the Clinical Pharmacist’s Role in the Management of Acute Pancreatitis: A Clinical Review Jad El Tom1, Alisar Serhan2, Tarek Safi3, Wissam K Kabbara4 1School of Pharmacy, Lebanese American University (LAU), Byblos, Lebanon; 2Hospital Pharmacist, Saint George Hospital University Medical Center, Beirut, Lebanon;3Saarland University Medical Center, Homburg, Germany; 4Clinical Associate Professor, Department of Pharmacy Practice, School of Pharmacy, Lebanese American University (LAU), Byblos, Lebanon. Introduction: The role of the clinical pharmacist in the management of acute pancreatitis has not been researched extensively, and only a few published studies on the topic can be found. This clinical review presents all pertinent published data and serves as a guide for clinical pharmacists who participate in the management of patients with acute pancreatitis. Methods: An extensive literature search was conducted on PubMed from 1990 to 2021 to retrieve relevant studies focusing on the role of the clinical pharmacist in the treatment of acute pancreatitis. Results: An analysis of the medications that are associated with acute pancreatitis is presented, highlighting the responsibility of the pharmacist to conduct a thorough medication investigation in order to identify a possible drug-induced acute pancreatitis. Medical management of acute pancreatitis, mainly fluid therapy, is an area where a clinical pharmacist can appropriately intervene. Proper choice of fluid therapy and its rate, nutritional considerations, pain management and antibiotic use, are all important to consider for a successful treatment with minimal adverse effects. It is well documented in the literature that clinical pharmacists can decrease hospital costs. Discharge counseling performed by a clinical pharmacist has been shown to increase patient compliance and decrease both readmission rates and follow-up physician visits. Conclusion: The clinical pharmacist, as the primary drug expert, can identify medication-induced pancreatitis, diminish the use of unnecessary antibiotics, improve patient care ...

Antibotics Which Distrbuted in the Hospital of Al Wahda (Derna, Libya) by Medical Supply Ward for 3 Months and Their Relations With Number of Patients Admitted and Compare These Antibiotics With Bacterial Culture Results Done by Laboratory

Research Article of International Journal of Hospital Pharmacy Antibotics Which Distrbuted in the Hospital of Al Wahda (Derna, Libya) by Medical Supply Ward for 3 Months and Their Relations With Number of Patients Admitted and Compare These Antibiotics With Bacterial Culture Results Done by Laboratory Mahmoud El Mabri1, Abduljaleel el-shalwi2, Bilal B Rafadi3 1Medical Supply Ward Wahda Hospital, Faculty of Pharmacy. Benghazi University, Derna Libya; 2Medical Supply Ward Wahda Hospital, Faculty of Pharmacy. Omar Elmokhtar University; 3Benghazi University, Derna Libya Antimicrobial resistance (and particularly antibiotic resistance) is spreading now, and there are few prospects for the development of new classes of antibiotics in the short term. However, there is today considerable awareness of the need for, and political support for, action to combat Antimicrobial resistance1. Surveillance of antimicrobial use tracks how and why antimicrobials are being used and misused by patients and healthcare providers. Monitoring antimicrobial prescription and consumption behavior provides insights and tools needed to inform therapy decisions, to assess the public health consequences of antimicrobial misuse, and to evaluate the impact resistance containment interventions2. And all reports from WHO tell us about post antibiotics era that will be start if we don’t work quickly on antibiotics resistance by all efforts and due to situations of my country in Libya now need a lot of studies to decrease corruption in budgets put for health sector. Experimental methods: Study made by pilot method and we depend on data collected from dispensing papers of medical supply ward in Al Wahda hospital. *medical statistics office of Al Wahda hospital *Al Wahda hospital laboratory. *data collected to 3 months and 477 in- patient of wahda hospital. Results and discussion: After collect data from dispensing paper that based on treatment chart, we covered 477 patients for 3 months by 2169 ceftri-702 gent-1360 aug-547 cefot-23amik ...

PASS Protocol Fever as basis of COVID-19 testing in Patient- A Union Therapy Initiative

Review Article of International Journal of Hospital Pharmacy PASS Protocol Fever as basis of COVID-19 testing in Patient- A Union Therapy Initiative Kanishk Kala, Rupinder Kaur Sodhi IK Gujral PTU Fever is the sole symptomatic measurement modality for Covid-19 screening which could be implemented easily all over the globe in with optimal utilization of resources. Being easy economical and easily reproducible, this has a potential to be a gold standard as well as simplicity of the procedure could help in its monitoring by patients itself and would operate an important element of patient involvement in treatment and would help in adherence in countries where health care staff are short and patient burden is high. This protocol will extend helping hands to health care worker and will involve patient participation in the treatment also. Keywords:COVID -19 , fever , Union Therapy , PASS protocol , Sayojya Chikitsa ...

Guidelines for Safe and Effective Use of Hydroxychloroquine in COVID-19 Patients

Review Article of International Journal of Hospital Pharmacy Guidelines for Safe and Effective Use of Hydroxychloroquine in COVID-19 Patients Hannah Ariel Department of Chemistry and Biochemistry, Queens College The emergent need to treat COVID-19 patient must be tempered with safe use of drugs. The guideline set forth provides parameters for dosing and monitoring hydroxychloroquine in this population, reducing the occurrence of adverse effects and improving overall pharmacotherapy. Keywords: Hydroxychloroquine, COVID-19 Patients, Safe and Effective Use ...

Manuscript Title: The title should be a brief phrase.

Author Information: List full names and affiliation of all authors, including Emails and phone numbers of corresponding author.

Abstract: The abstract should be less than 500 words. Following abstract, a list of keywords and abbreviations should be added. The keywords should be no more than 10. Abbreviation are only used for non standard and long terms.

Introduction: The introduction should included a clear statement of current problems.

Materials and Methods: This section should be clearly described.

Results and discussion: Authors may put results and discussion into a single section or show them separately.

Acknowledgement: This section includes a brief acknowledgment of people, grant details, funds

References: References should be listed in a numbered citation order at the end of the manuscript. DOIs and links to referenced articles should be added if available. Abstracts and talks for conferences or papers not yet accepted should not be cited. Examples Published Papers: 

1. Hongmei YANG. A study on the Management Mode of Modern Vocational Education in China. Global journal of Economics and Business Administration, 2018, 3: 10.DOI: 10.28933/gjeba-2018-07-2301 

Tables and figures: Tables should be used at a minimum with a short descriptive title. The preferred file formats for Figures/Graphics are GIF, TIFF, JPEG or PowerPoint.

Publication fees: We do not charge any submission charges, but authors are required to pay publication fees after their manuscripts are accepted for publication. For authors who receive our invitations, please send us the invitation code to receive the special discount.

Proofreading and Publication: A proof will be sent to the corresponding author before publication. Authors should carefully read the proof to avoid any errors and return the proof to the editorial office. Editorial office will publish the article shortly.

Withdrawal Policy: When you want to withdraw an article, please contact us. We will withdraw/retract it from our system after reviewing your request.

Terms of Use/Privacy Policy/Disclaimer/Other Policies: you agree that by using or receiving our services, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies.

About the journal
The journal is hosted by eSciPub LLC. Our aim is to provide a platform that encourages publication of the most recent research and reviews for authors from all countries.


About the publisher
eSciPub LLC is a publisher to support Open Access initiative located in Houston, Texas, USA. It is a member of the largest community of professional publishers in the United States: the Independent Book Publishers Association. It hosts more than 100 Open Access journals in Medicine, Business & Economics, Agriculture, Biological Sciences, Chemistry, Education, Physical Sciences, Sociology, and Engineering and Technology.


Rapid Response Team
Please feel free to contact our rapid response team if you have any questions. Our customer representative will answer your questions shortly.

International Journal of Hospital Pharmacy

Loading